[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Antiangiogenic properties of gold nanoparticles

Clin Cancer Res. 2005 May 1;11(9):3530-4. doi: 10.1158/1078-0432.CCR-04-2482.

Abstract

Here, we report an intrinsic property of gold nanoparticles (nanogold): they can interact selectively with heparin-binding glycoproteins and inhibit their activity. Gold nanoparticles specifically bound vascular permeability factor/vascular endothelial growth factor (VPF/VEGF)-165 and basic fibroblast growth factor, two endothelial cell mitogens and mediators of angiogenesis resulting in inhibition of endothelial/fibroblast cell proliferation in vitro and VEGF-induced permeability as well as angiogenesis in vivo. In contrast, nanogold did not inhibit VEGF-121 or epidermal growth factor, two non-heparin-binding growth factors, mediated cell proliferation. Gold nanoparticles significantly inhibited VEGF receptor-2 phosphorylation, intracellular calcium release, and migration and RhoA activation in vitro. These results report for the first time a novel property of gold nanoparticles to bind heparin-binding proteins and thereby inhibit their subsequent signaling events.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Angiogenesis Inhibitors / pharmacology*
  • Angiogenesis Inhibitors / therapeutic use
  • Animals
  • Calcium / metabolism
  • Cell Line
  • Cell Line, Tumor
  • Cell Movement / drug effects
  • Cell Proliferation / drug effects
  • Endothelial Cells / cytology
  • Endothelial Cells / drug effects
  • Fibroblast Growth Factor 2 / pharmacology
  • Gold / pharmacology*
  • Gold / therapeutic use
  • Humans
  • Intracellular Space / drug effects
  • Intracellular Space / metabolism
  • Male
  • Mice
  • Mice, Inbred C3H
  • Mice, Nude
  • NIH 3T3 Cells
  • Nanotechnology
  • Neoplasm Transplantation
  • Neoplasms, Experimental / blood supply
  • Neoplasms, Experimental / pathology
  • Neoplasms, Experimental / prevention & control
  • Neovascularization, Pathologic / prevention & control
  • Particle Size
  • Phosphorylation / drug effects
  • Umbilical Veins / cytology
  • Vascular Endothelial Growth Factor A / pharmacology
  • Vascular Endothelial Growth Factor Receptor-2 / metabolism

Substances

  • Angiogenesis Inhibitors
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Fibroblast Growth Factor 2
  • Gold
  • Vascular Endothelial Growth Factor Receptor-2
  • Calcium